Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2375 SEK | -0.63% | -13.79% | -21.62% |
Business Summary
Number of employees: 3
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andreas Gerward
CEO | Chief Executive Officer | 36 | 31/12/13 |
Mattias Münnich
FOU | Founder | 45 | 31/12/14 |
Thomas Pålsson
DFI | Director of Finance/CFO | 72 | 31/12/17 |
Chief Tech/Sci/R&D Officer | 65 | 31/12/22 | |
Anders Lehmann
CTO | Chief Tech/Sci/R&D Officer | 67 | 31/12/14 |
Sara Richardson
LAW | General Counsel | 53 | 31/12/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 29/06/21 | |
Erik Kinnman
BRD | Director/Board Member | 66 | 31/12/19 |
Ulf Björklund
CHM | Chairman | 68 | 01/06/21 |
Gudrun Anstrén
BRD | Director/Board Member | 69 | 31/12/20 |
Director/Board Member | 49 | 31/12/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,720,903 | 25,587,807 ( 80.67 %) | 0 | 80.67 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-21.62% | 696K | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |
- Stock Market
- Equities
- STABL Stock
- Company Stayble Therapeutics AB